483 Shandong Anshun Pharmaceutical Nov 2020

483 Shandong Anshun Pharmaceutical Nov 2020

Marcus Ray FDA$119.00 - Available Now

FDA investigators audited the Shandong Anshun Pharmaceutical - Dezhou, China facility and issued inspectional observations (via FDA 483) on 20 Nov 2020.

Product details

  • Category: Human Drugs
  • Inspection end: 20 Nov 2020
  • Location: Dezhou, China
  • FEI: 3015326904
Add To Cart